摘要
2011年ACCF/AHA临床指南工作组根据近年临床试验的结果对目前心房颤动(房颤)的治疗指南提出重点更新建议,主要有:(1)心室率控制策略的新认识:严格还是宽松;(2)房颤抗栓的新方案和新药物(达必加群);(3)决奈达隆用于房颤转复、维持窦性心律以及对经导管消融治疗房颤的新观点。作者根据对相关临床资料的回顾提出了对指南更新要点的思考和认识。
The American College of Cardiology Foundation/American Heart Association(ACCF/AHA) Task Force on Practice Guidelines delivered focus update on the management of patients with atrial fibrillation(Af) according to outcomes of new cinical trials.Recommendations are on three areas,including(1) new recommendations for heart rate control of Af: strict or lenient (2) new antithrombotic therapy and new antithrombotic agent(dabigatran),and(3) use of dronedarone for prevention of recurrent Af and new opinion in catheter-based ablation therapy for Af.The author brings up some perspectives of these recommendations after reviewing evidence supporting current update.
出处
《心血管病学进展》
CAS
2011年第3期314-317,共4页
Advances in Cardiovascular Diseases
关键词
心房颤动
治疗
解读
atrial fibrillation
management
interpretation